1	Mujer	mujer	NCFS000	C0043210#C0015780#C0086418	persona#hallazgo#estructura_corporal#organismo_vivo	0-5	20_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
2	de	de	SPS00	C0332285	atributo	6-8	20_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
3	71	71		-	-	9-11	20_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
4	años	año	NCMP000	C0439234	calificador	12-16	20_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
5	,	,	Fc	-	-	16-17	20_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
6	con	con	SPS00	C0332287	atributo	18-21	20_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
7	antecedentes	antecedente	NCMP000	C0332119_1	situación_1	22-34	20_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
8	de	de	SPS00	C0332119_2	situación_2	35-37	20_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
9	artritis	artritis	NCFN000	C0003873_1	trastorno_1	38-46	20_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-	-	-	-
10	reumatoide	reumatoide	AQ0CS0	C0003873_2	trastorno_2	47-57	20_QUEST_clinical_caseMIR	SENT1	B-Calificador	-	9	2523	Modif
11	en	en	SPS00	C1720294#C0332285	calificador#atributo	58-60	20_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
12	tto	tratamiento	NC00YL0	C1273870#C0087111	procedimiento#régimen/tratamiento	61-64	20_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
13	con	con	SPS00	C0332287	atributo	65-68	20_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
14	sulfasalazina	sulfasalazina	NC00SC0	C0036078	sustancia	69-82	20_QUEST_clinical_caseMIR	SENT1	B-Grp_Medicamento	-	-	-	-
15	,	,	Fc	-	-	82-83	20_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
16	prednisona	prednisona	NCFS000	C0032952	sustancia	84-94	20_QUEST_clinical_caseMIR	SENT1	B-Grp_Medicamento	-	-	-	-
17	y	y	CC	C1706368	calificador	95-96	20_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
18	etanercept	etanercept	NC00SC0	C0717758#C0018100	producto#sustancia	97-107	20_QUEST_clinical_caseMIR	SENT1	B-Grp_Medicamento	-	-	-	-
19	.	.	Fp	-	-	107-108	20_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-

1	Acude	acudir	VMIP3S0	-	-	109-114	20_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
2	a	a	SPS00	-	-	115-116	20_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
3	URG	urgencias_(servicio_de)	NC00YL0	-	-	117-120	20_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
4	por	por	SPS00	C0678226	atributo	121-124	20_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
5	clínica	clínica	NCFS000	C0442592	medio_ambiente	125-132	20_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
6	de	de	SPS00	C0332285	atributo	133-135	20_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
7	72	72	Z	C1292423_1	calificador_1	136-138	20_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
8	horas	hora	NCFP000	C1292423_2	calificador_2	139-144	20_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
9	compatible	compatible	AQ0CS0	C0332290#C1524057_1	calificador#atributo_1	145-155	20_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
10	con	con	SPS00	C0332290#C1524057_2	calificador#atributo_2	156-159	20_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
11	Herpes	herpes	NCMN000	C0019360_1	trastorno_1	160-166	20_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	-	-	-	-
12	Zóster	zóster	NC00SC0	C0019360_2	trastorno_2	167-173	20_QUEST_clinical_caseMIR	SENT2	I-Grp_Enfermedad	-	11	62	MultiE
13	facial	facial	AQ0CS0	-	-	174-180	20_QUEST_clinical_caseMIR	SENT2	B-Estructura_Corporal	-	11	2524	LOC
14	afectando	afectar	VMG0000	-	-	181-190	20_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
15	a	a	SPS00	-	-	191-192	20_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
16	a	a	SPS00	-	-	193-194	20_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
17	hemicara	hemicara	VMSI3S0	-	-	195-203	20_QUEST_clinical_caseMIR	SENT2	B-Estructura_Corporal	-	-	-	-
18	derecha	derecha	NCFS000	-	-	204-211	20_QUEST_clinical_caseMIR	SENT2	I-Estructura_Corporal	-	17	164	MultiE
19	,	,	Fc	-	-	211-212	20_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
20	pabellón	pabellón	NCMS000	C0557665#C0227911	medio_ambiente#estructura_corporal	213-221	20_QUEST_clinical_caseMIR	SENT2	B-Estructura_Corporal	-	-	-	-
21	auricular	auricular	AQ0CS0	-	-	222-231	20_QUEST_clinical_caseMIR	SENT2	I-Estructura_Corporal	-	20	63	MultiE
22	,	,	Fc	-	-	231-232	20_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
23	respetando	respetar	VMG0000	-	-	233-243	20_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
24	frente	frente	RG	C1284847#C0016540#C0549224	estructura_corporal	244-250	20_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
25	y	y	CC	C1706368	calificador	251-252	20_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
26	quemosis	quemosis	NCFN000	C0271298	trastorno	253-261	20_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	-	-	-	-
27	conjuntival	conjuntival	AQ0CS0	-	-	262-273	20_QUEST_clinical_caseMIR	SENT2	B-Estructura_Corporal	-	26	2524	LOC
28	.	.	Fp	-	-	273-274	20_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-

1	¿	¿	Fia	-	-	275-276	20_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
2	Cuál	cuál	PT0CS000	-	-	276-280	20_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
3	sería	ser	VSIC1S0	-	-	281-286	20_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
4	el	el	DA0MS0	-	-	287-289	20_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
5	tratamiento	tratamiento	NCMS000	C1273870#C0087111	procedimiento#régimen/tratamiento	290-301	20_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
6	adecuado	adecuar	VMP00SM	-	-	302-310	20_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
7	?	?	Fit	-	-	310-311	20_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
8	.	.	Fp	-	-	311-312	20_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-

